HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C F Bennett Selected Research

ISIS 9125

9/2002Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C F Bennett Research Topics

Disease

4Inflammation (Inflammations)
10/2002 - 02/2000
2Neoplasms (Cancer)
03/2004 - 05/2001
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2002 - 09/2002
2Reperfusion Injury
11/2001 - 02/2001
1Cerebellar Ataxia (Dysmetria)
01/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2004
1Lymphoma (Lymphomas)
03/2004
1Ileitis
10/2002
1Heart Block
09/2001
1T-Cell Lymphoma (Lymphoma, T Cell)
09/2001
1Gram-Negative Bacterial Infections
05/2001
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2000
1Vascular Diseases (Vascular Disease)
02/2000
1Infections
02/2000
1Virus Diseases (Viral Diseases)
02/2000
1Contact Dermatitis (Eczema, Contact)
02/2000
1Splenomegaly
02/2000
1Down Syndrome (Down's Syndrome)
02/2000
1Hypersensitivity (Allergy)
02/2000
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
02/2000
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2000

Drug/Important Bio-Agent (IBA)

7Antisense OligonucleotidesIBA
03/2004 - 11/2000
6Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2002 - 02/2000
2SurvivinIBA
03/2004 - 05/2001
2OligonucleotidesIBA
02/2000 - 02/2000
2OligodeoxyribonucleotidesIBA
02/2000 - 02/2000
1cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- somatostatin (CHP1)IBA
01/2022
1Rituximab (Mabthera)FDA Link
03/2004
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2002
1Indomethacin (Indometacin)FDA LinkGeneric
10/2002
1HLA-B27 Antigen (HLA B27 Antigen)IBA
09/2002
1Pharmaceutical PreparationsIBA
09/2002
1ISIS 9125IBA
09/2002
1Concanavalin AIBA
09/2001
1Interleukin-2 (IL2)IBA
09/2001
1LipopolysaccharidesIBA
05/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2001
1Dacarbazine (DIC)FDA LinkGeneric
02/2000
1Messenger RNA (mRNA)IBA
02/2000
1Liposomes (Liposome)IBA
02/2000